Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00253383 · ClinicalTrials.gov registry record · NA
Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients
A NA study, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 329
- Enrollment target
NCT00253383: Completed NA study, sponsored by Dartmouth-Hitchcock Medical Center.
NCT00253383 is a NA study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 329 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00253383, a NA study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 329 participants
- Enrollment target
Study Summary
RATIONALE: Palliative care may help patients with advanced cancer live more comfortably. PURPOSE: This randomized clinical trial is studying an early intervention palliative care program to see how well it works compared to a standard care program in improving end-of-life care in patients with advanced lung , gastrointestinal, genitourinary, or breast cancer.
Interventions
- PROCEDURE quality-of-life assessment
- OTHER educational intervention
- OTHER counseling intervention
- PROCEDURE psychosocial assessment and care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 329 participants |
| Start Date | 2003-01 |
| Est. Completion | 2013-09 |
| Phase | NA |
What the finished NCT00253383 record still lists
NCT00253383 is an interventional study that assigns participants to a tested intervention. The registered 329 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower).
The record links to 0 conditions, and to 4 interventions - of which quality-of-life assessment is the first listed.
NCT00253383 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00253383 about?
NCT00253383 is a clinical study titled "Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients". RATIONALE: Palliative care may help patients with advanced cancer live more comfortably. PURPOSE: This randomized clinical trial is studying an early intervention palliative care program to see how well it works compared to a standard care program in improving end-of-life care in patients with adva...
What is the current status of trial NCT00253383?
This trial is currently completed. It is a NA study. The enrollment target is 329 participants. The study started on 2003-01. Estimated completion is 2013-09.
What interventions are being tested in trial NCT00253383?
The interventions under investigation include: quality-of-life assessment (PROCEDURE), educational intervention (OTHER), counseling intervention (OTHER), psychosocial assessment and care (PROCEDURE).
Who is sponsoring clinical trial NCT00253383?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00253383's enrollment target sits among peer trials
329 308th of 2000 higher than 1,693 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06036446 · 329 participants · NA
LATe Cerclage in High-risk Pregnancies (LATCH)
- NCT00359684 · 330 participants
Use of Cysteamine in the Treatment of Cystinosis
- NCT03817502 · 330 participants · Phase 3
Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
- NCT03922724 · 330 participants · Phase 2
Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia